Markets:

Overview

News

Currencies

International

Treasuries

23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals

May 14, 2024

Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activity

From 23andMe, Inc.

Via GlobeNewswire

23andMe to Report Q4 and Full Year FY2024 Financial Results

May 09, 2024

From 23andMe, Inc.

Via GlobeNewswire

Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case

April 30, 2024

From Potter Handy LLP

Via Business Wire

Looking Into 23andMe Holding's Recent Short Interest ↗

March 29, 2024

Via Benzinga

Looking Into 23andMe Holding's Recent Short Interest ↗

March 04, 2024

Via Benzinga

Is 23andMe Stock a Smart Buy Right Now? ↗

February 13, 2024

It's having trouble getting its core business model to work.

Via The Motley Fool

23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

April 24, 2024

Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented

From 23andMe, Inc.

Via GlobeNewswire

This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next ↗

April 23, 2024

Matterport is being acquired by a real estate giant, but it might not be the last ex-SPAC to go this route.

Via The Motley Fool

Nasdaq Down 0.5%; Lithium Americas Shares Slide ↗

April 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 18, 2024

Via Benzinga

Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher ↗

April 18, 2024

Via Benzinga

Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future ↗

April 18, 2024

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential...

Via Benzinga

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 18, 2024

Via Benzinga

Why Is Lithium Americas (LAC) Stock Down 28% Today? ↗

April 18, 2024

Lithium Americas stock is falling on Thursday after the lithium mining company announced the pricing of a public offering for LAC shares.

Via InvestorPlace

Walgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts ↗

April 18, 2024

Walgreens layoffs are in the news Thursday after the pharmacy chain announced plans to cut jobs in Chicago while reducing employees' hours.

Via InvestorPlace

Topics Workforce

ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal ↗

April 18, 2024

23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 18, 2024

Via Benzinga

23andMe announces CEO’s intention to pursue a potential take-private

April 18, 2024

From 23andMe, Inc.

Via GlobeNewswire

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024

April 05, 2024

From 23andMe, Inc.

Via GlobeNewswire

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead? ↗

March 24, 2024

Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

Via The Motley Fool

23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6

March 20, 2024

From 23andMe, Inc.

Via GlobeNewswire

23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago

March 19, 2024

Built upon peer-reviewed published science, the Historical Matches feature weaves customers’ ancestral connections into the story of human history and migration

From 23andMe, Inc.

Via GlobeNewswire

A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock ↗

March 16, 2024

Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside.

Via The Motley Fool

23andMe Launches New Genetic Reports on Common Forms of Cancer

March 06, 2024

23andMe customers can now gain deeper insight into their likelihood of developing breast, colorectal, and prostate cancer through new reports based on polygenic risk scores (PRS) developed by 23andMe

From 23andMe, Inc.

Via GlobeNewswire

23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024

March 05, 2024

23andMe to give an oral presentation on the genetic signature of ULBP6, the target of 23ME-01473, along with poster presentations of the biology of ULBP6 and mechanism of 23ME-01473, and new...

From 23andMe, Inc.

Via GlobeNewswire

Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2024

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown...

Via Benzinga

Former YouTube CEO's Teenaged Son Found Dead At UC Berkeley ↗

February 18, 2024

The 19-year-old's grandmother, Esther Wojcicki, known as the "Godmother of Silicon Valley," says his death was likely a drug overdose.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 12, 2024

Via Benzinga

Crude Oil Gains 3%; Kellanova Posts Upbeat Results ↗

February 08, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 30 points on Thursday. The Dow traded down 0.01% to 38,675.29 while the NASDAQ rose 0.19% to 15,787.09. The...

Via Benzinga

Topics Stocks

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 08, 2024

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.